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Specific response of superficial and deep nephrons to the expansion of
extracellular volume in the rat. J. 1VI. López-Novoa, M. 1'. NegrOn, M.
A. Cruz-Soto, Al. MartInez—Maldonado, Renal-Metabolic Laboratory,
Veterans Adminstration Center, San Juan, Puerto Rico, and Lahora-
tory of Renal Physiology, Fundación Jiménez DIaz, Madrid, Spain. The
response to volume expansion with saline 110% b.w.) was examined in
rats, 2 days after induction of unilateral cortical necrosis (CN) by
immersion of the kidney during 5 sec in boiling water. The contralateral
kidney was used as control (CK). Juxtamedullary tiM.) nephrons
predominated in the CN kidney. The number of functioning glomeruli
was counted after carotid injection of indian ink, and mean single
nephron filtration rate and plasma flow were obtained by dividing whole
kidney values between the number of functioning nephrons. These data
were compared with the values obtained by micropuncture studies on a
similar group of animals, In basal conditions,single nephron filtration
rate of 3M nephrons (JMFR) was 1.5 times higher than that of
superficial nephrons (SNFR). After volume expansion, SNF'R in-
creased by 27.3% whereas JMGFR did not change. Volume expansion
induced an 80.6% increase in plasma flow through JM nephrons and
only a 23.1% in superficial nephrons. Micropuncture data confirmed
these values for superficial nephrons. Fractional excretion of sodium
was higher in CN than in CK in basal conditions, but after volume
expansion both values were similar. CN kidney showed a greater
fractional water excretion after volume expansion. These studies sug-
gest that (1) volume expansion causes redistribution of filtration rate
toward superficial nephrons and of plasma flow to JM nephrons; (2)
after volume expansion both kinds of nephrons handle Na and K in a
similar way, but JM nephrons produced a more diluted urine; (3) this
model of CN seems to be suitable for the in vivo study of functional
characteristics of deep nephrons.
A micropuncture study of renal function after extracellular volume
expansion in cirrhotic rats. Jose Miguel López-Novoa. Laboratory of
Renal Physiology, FundaciOn Ji,nénez DIaz, Madrid. and Renal-Meta-
bolic Laboratory, Veterans Administration Center, San Juan, Costa
Rica. The kidney function and the segmental handling of water and
sodium by the individual nephrons in control (N) and cirrhotic (CH) rats
after extracellular volume expansion (EVE) were studied. Micropunc-
ture and clearance studies were performed in six N and CH rats before
and after EVE (3% body wt plus reposition of urinary losses). Tubular
fluid samples were obtained from late proximal (LP), early distal (ED),
and late distal (LD) convolutions of superficial nephrons. N and CH
rats showed similar GFR and RPF, but CH animals had a tower FEN.
than control animals. After EVE, GFR and Rl'F increased in both
groups of rats, butCH rats had FEN. values lower than N ones (0.61
0.003 vs. 1.49 0.15,P <0.005). Also the ratio SNGFR/GFR increased
from 19.6 0.7 to 21.2 1.0 (arbitrary units; P < 0.005) in N rats hut
did not change in CH rats. Before EVE, CH rats had a higher TF/P, in
LP and LD samples than N animals without differences in ED samples.
After EVE both N and CH rats showed a decrease in TF/P1,, in all the
segments. Fractional reabsorption (FR) in N rats decreased in LP and
ED hut did not change in LD. In CH rats FR decreased in lP and LD
but did not change in ED. In this segment net tubular reabsorption
(NTR) increased from 5.1 0.4 to 6.9 0.5 nI/mm after EVE (P <
0.05). Both TF/P1 and FR were higher in CH rats than in N rats in all
the segments studied after EVE. 'The data support that the lack of
significant natriuresis after EVE in CH rats depends on the combination
of at least two factors: lack of intrarenal GFR redistribution and
inadequate decrease of tubular reabsorption.
Renal management and study of the Tm of lactate in dogs: study of
acute lactic acidosis and alkalosis. F. Junco, R. Perez Garcia, R. Jofre,
F. Valderrdhano, A. Goagoux, P. Vinay, and Ci. Lemieux. Renal
Laboratory, Hdrel-Dieu Montreal, Quebec, CanadO, and Servicio de
Nefrologla, Hospital Provincial Madrid (Spain). The renal management
of lactate in dogs is not well known, because controversy exists over
lactate tubular reabsorption (LTR) and possible existence of a Tm.
Other investigators have worked with dogs under normal lactate acid-
base equilibrium; therefore, we studied the renal management of lactate
in normal dogs (N = 12), in dogs under acute lactic acidosis canditions
(LAC) (N = 6) and in acute lactic alkalosis (LAL) (N = 6) administrat-
ing lactic acid and sodium lactate, respectively, during 60 mm. In all
dogs, arterial acid-base equilibrium, glomerular filtration (GFR), renal
blood flow (RI3F), and enzyme dosification of arterial and urinary
lactate were serially determined. in LAC (pH 7.09) and LAL (pH 7.45)
no significant differences in GFR nor RBF with respect to normal dogs
exist. Under normal lactate levels (1.28 0.25 tM/ml) the LTR exceeds
over 99% the lactate filtrated. No variation in the LTR exists with
respect to normal dogs despite the lactic acidosis or alkalosis. In all
cases, a close correlation between the amount of lactate filtrated and its
tubular reabsorption exists (P < 0.05). The lactate excretion is signifi-
cant once 6 to 8 tIM/mI of arterial lactate level is reached obtaining
levels superior to 10% of the lactate filtrated, reaching a Tm of 300 80
/LM/min at a lactic arterial level of 11.2 3.3 tM/ml. In conclusian, a
lactic Tm in the dog kidney is proven. This Tm does not vary with the
modifications of the lactate acid-base equilibrium, possibly because
significant variations in renal hemodynamics do not exist. Even with
normal blood lactate levels, the lactate tubular reabsorption is not
complete, and it appears to take place in the proximal tubule, being
doubtful of the existence of distal secretion since a Tm has been
obtained. No differences in the LTR in acute lactic acidosis nor
alkalosis exist with respect to dogs under normal acid-base equilibrium
conditions.
Long.term renal function following acute renal failure in the newborn.
I. Zamora, S. Mendizahal, A. Lurbe, A. Barbadillo, J. Simon. Paediat-
nc Nephrology Unit, Hospital lqtOntil LA FE Valencia, Spain. A long-
term follow-up study of 27 survivors of acute renal failure (ARF) in
newborns was performed. A study of the evolution of renal function
was possible in 20 patients with follow-up periods ranging from 3.7 to
7.7 years (mean, 5.6 years). Renal function was determined by assess-
ing glomerular filtration rate (GFR), free-water reabsorption (T1j,)),
tubular reabsorption of phosphate (TRP and Tm) and acidification
ability (HCO3 threshold and U5. Renal growth was estimated from
the measure of kidney length in urographic films. Results show an
evolutive difference, according to the etiology of the ARF: (1) The six
patients with ARF caused by neonatal hypoxia and shock maintained
nephrological sequels. Five maintain a decreased GFR thus far (52 to 77
ml/min/1.73 m2). Three displayed urinary acidification disorders (proxi-
mal and/or distal renal tubular acidosis). Unilateral renal growth stop
was observed in five of the six patients showing that their biopsy
specimens had no relevant histologic alterations. (2) The 14 patients in
which ARF was related to hypovolemic shock, caused by hypertonic
dehydration, showed normal renal function after 6 to 12 months. A
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defect in TH,o was found in most patients of both groups, during the
first year. The THO remained abnormal after 3 to 6 years in five patients
of group 1, although in relation to decreased GFR.
Comparative study between three techniques for detection of circulat-
ing immune complexes. Their application on patients with various
glomerular nephropathies. E. Mirapeix, L. Borche, P. tv/as, C. Moreno,
J. Vives, and L. Revert. Servicio de NefrologIa, Servicio de Inmunolo-
gIa, Hospital ClInico y Provincial de Barcelona, Spain. Eighty-eight
sera of patients with various primary and secondary glomerular dis-
eases were studied, measuring complement components C3, C4, CH5O,
nephritic factor, and circulating immune complexes (CIC) with three
tests: Microcomplement consumption test (MCT), Clq-binding assay
(Clq-BA), and the polyethylene glycol precipitation complement con-
sumption test (PEG-CC). The best correlation with the clinical and
histopathological features was obtained with PEG-CC, followed by
Clq-BA. The MCT gave false positive results very often. The PEG-CC
could distinguish between active and nonactive acute poststreptococcal
glomerulonephritis (AGN) showing better correlation with the clinical
status than the complement profile. Sera from nephrotic syndrome and
membranous nephropathy that showed CIC with PEG-CC and Clq-BA
corresponded to patients with nonidiopathic forms of these diseases
(lupus, rheumatoid, arthritis, HbAg+, and syphilis) supporting the
opinion that minimal change disease is not mediated by CIC and the
immune complexes of membranous nephropathy are formed in situ.
The high percentage of patients with mesangiocapillary glomerulone-
phritis showing CIC (42%) suggest that CIC contribute to the pathogen-
esis of this disease and could cause complement activation by the
classical pathway.
Increased rates of polymeric IgA synthesis by circulating lymphoid cells
in IgA nephropathy. J. Egido, R. Blasco, J. Sancho, L. Lozano, M.
Sanchez Crespo, and L. Hernando. Fundacion Ji,nenez Diaz, Madrid,
Spain. Recently, we described the existence of high levels of polymeric
IgA, partially as immune complexes, in the serum and kidney from
patients with IgA nephropathy. As these patients often have macro-
scopic hematuria following upper respiratory tract infections, our
working hypothesis was that circulating lymphocytes from secretory
tissues after viral stimulus could produce in these patients a large
amount of polymeric IgA. To test it, peripheral blood lymphocytes(PBL) from patients and controls were cultured for 7 days in the
presence or absence of pokeweed mitogen (PWM). In cell culture
supernatants immunoglobulin synthesis was measured by RIA and the
proportion of polymeric and monomeric IgA was determined on Ultro-
gel Ac A22 column. There was no difference in spontaneous production
of immunoglobulins between patients and controls. On the contrary, the
IgA synthetized by PWM-stimulated PBL was significantly higher in
patients than in controls. The percentages of IgA comprised between
600,000 and 250,000 daltons after supernate fractionation was signifi-
cantly higher in patients than in controls. The true nature of polymeric
IgA was confirmed by their ability to bind secretory component, the
existence of covalent structures, and the decrease of the larger forms of
IgA after reduction and alkylation. The percentage of IgA producing
cells binding secretory component was significantly higher in patients
than in controls (69 21 vs. 44 27) after 7 days of culture. 1gM and
lgG produced in culture of patients were similar to controls. These
results show that in vitro mitogen-stimulated PBL from patients with
Berger disease synthetized a large amount of true polymeric IgA. It is
suggested that a similar situation could occur in vivo after viral or other
stimuli.
Study of IgA and IgG immune complexes in IgA nephropathy. J.
Egido, J. Sancho, F. Rivera, and L. Hernando. Fundacion Jimenez
Diaz. Madrid, Spain. We have searched for the prevalence of IgA
immune complexes (IC) in 170 sera from 54 patients with IgA nephrop-
athy by two different techniques: (I) the Raji cell assay modified for IgA
and (2) the anti-IgA inhibition binding assay. IgG-IC were also studied
by the classical Raji cell assay. Forty percent of patients presented IgA-
IC, 55% IgG-IC by the Raji cell assay, and between Ii and 41% by the
anti-IgA inhibition binding assay, respectively, according to polyethyl-
ene glycol precipitation or not. A correlation was found only between
the presence of IgA-Raji IC and hematuria. However, no correlation
was observed between the IgA-IC and TgG-IC and proteinuria, renal
function and serum IgA levels. Patients with IgA-Raji IC had signifi-
cantly higher levels of polymeric IgA in serum than those who had not.
At the moment of the kidney biopsy patients with IgG (+) in the
mesangium had more IgG-Raji IC than those with IgC (—). Both
intermediate and large IgA-IC were found in the serum. Patients treated
for 1 year with phenytoin had significantly less IgA Raji-IC than the
control group. These findings suggest that IC containing bound comple-
ment breakdown products seem to correlate better with disease activi-
ty. High levels of polymeric IgA favored the persistence of IC in the
circulation. The utility of the determination of blood IC in IgA nephrop-
athy in clinical practice remains to be established.
Glomerulonephritis with isolated mesangial C3 deposition. A. Torras,
E. Bergadd, J. Montoliu, A. Darnell, and L. Revert. Servicio Nefrolo-
gla, Hospital Clinico, Barcelona, Spain. Ten patients sharing the
common feature of isolated mesangial C3 deposition without other
complement components or immunoglobulins were identified out of a
total of 729 renal biopsy specimens. Clinically, four of these patients
presented with recurrent gross hematuria. five with proteinuria and
microscopic hematuria and one with proteinuria alone. When biopsied,
serum creatinine was normal in six patients and lower than 2.3 mg/dl in
the remaining four. Daily proteinuria ranged from < 0.2 to 6 g/24 hr
(mean 3 g/24 hr). Two patients had family histories of renal disease that
could not be clarified further. One patient suffered also from chronic
liver disease and another one from Hodgkin disease. On optic micro-
scopic, the glomeruli showed minimal mesangial proliferation in two
patients, endocapillary proliferative glomerulonephritis in three pa-
tients, focal lesions in three patients and interstitial fibrosis and
infiltrates in the other two. Mesangial electron dense deposits were seen
by electron microscopy in the five patients studied. In addition, three
patients had sporadic subepithelial deposits. After a mean follow-up of
12 months, the clinical features remain unchanged in all patients,
without worsening of renal function.
Effect of indomethacin administration upon renal function, protein-
uria, renin-angiotensin-aldosterone axis, and urinary prostaglandin E2 in
nephrotic syndrome. V. Gutierrez Millet, L. M. Ruilope, J. M. Alcazar,
C. Bernis, C. Prieto, J. F. Tresguerres, R. Garcia Rob/es, and J. L.
Rodicio. C.S.°1° de Octubre", Madrid, Spain. To investigate the
effect of indomethacin (I) administration (2 mg/kg b.w./day/3 days)
upon body weight (BW), blood pressure (BP), glomerular filtration rate
(GFR), proteinuria (P), natriuresis (UNa), PRA, plasma aldosterone
(PA), and urinary PGE2 excretion, a group of 21 patients diagnosed as
having normotensive chronic idiopathic glomerulonephritis was stud-
ied. In 12 patients a nephrotic syndrome (NS) was present (proteinuria
> 3.5 Gr/day). A group of 27 normotensive volunteers, sex- and age-
matched, was used as a control group (CG). The group of patients with
NS exhibited lower values of U, (P < 0.05) and higher values of PRA
(P < 0.02), PA (P < 0.05) and urinary PGE2 (P < 0.01) than those
without NS and CG. The administration of(l) induced in NS patients an
increase in BW (P <0.02) together with a decrease in GFR(P <0.01), P
(P <0.01), UNa(P <0.05), PRA (P <0.01), PA (P <0.01), and urinary
PGE2 (P < 0.01). BP did not change. In patients with glomerulonephri-
tis without NS, (1) induced a decrease in P (P < 0.01), PRA (P < 0.01),
PA (P < 0.01), and urinary PGE2 (P < 0.01) while BW, BP, GFR, and
UN. did not change. Two days after (I) withdrawal the modified
parameters had returned to previous values, in NS patients the decre-
ment of P induced by (I) correlated with the decrement of PRA (r =
0.711, P < 0.02) and PGE2 (r = 0.759, P < 0.02) but not with the
decrement of GFR. The diminution of GFR correlated with basal
urinary PGE, levels (r = 0.636, P < 0.05). In conclusion, in NS the
negative effect of (I) upon GFR correlated with the basal urinary levels
of PGE2. The antiproteinuric effect of (I) seems to be dependent on the
inhibition on renin-angiotensin axis and renal PGE2 synthesis. Albeit
the presence of high levels of PRA or PGE2 is not necessary to find a
diminution of proteinuria with (I) administration, in chronic glomerulo-
nephritis without NS.
Prognostic value of the hypothalamic-pituitary-adrenal axis in the
minimal change nephropathy. J. M. López-Gómez, M. J. Canals, M. C.
BOrcenas, F. J. GOmez-Campderd, M. Rengel, M. D. Morales, A.
López-Ramos, and A. Luque. Sección de Nefro/ogIa Pedidtrica, Ilospi-
tal Provincial, Madrid. Spain. Hypothalamic-pituitary-adrenal axis was
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evaluated in 45 children with minimal-change nephrotic syndrome (aged
4 to 5 years). The study consisted of baseline cortisol levels (9 A.M.
and Il P.M.) and ACTH stimulation test, before and after prednisone
treatment. Twenty-nine patients were infrequent relapsers (lR) and 1
were frequent relapsers (FR) (three or more relapsers and each new
relapser within 3 months after the end of the previous treatment).
During relapse and before treatment, 8 AM. cortisol level was signifi-
cantly lower in the FR group than in the JR group (P < 0.01) and while
the circadian rhythm was normal in the IR group (decrease of 75.6%), it
was altered in the FR group (decrease of 51.9%). The response to the
ACTH test was normal in all the cases. The tests performed I month
after the full treatment on alternate days with prednisone showed a
lower 8 AM. cortisol level in the FR group than in the IR group (P <
0.01) and the decrease of the circadian rhythm was also lower in the FR
group than in the IR group (53.7 vs. 71.2%). It is concluded that
hypothalamic-pituitary-adrenal axis is altered in the FR minimal-change
nephrotic syndrome. The recovery of the adrenal cortex after predni-
sone treatment is minor in the FR group than in the IR group, and the
state of the axis has a predictive value in the postmedication follow-up.
Vascular actions of the antihypertensive polar renomedullary lipid
(APRL or PAF-acether) in the rat. M. Sanchez Crespo, F. A/ease, V.
Alvarez, P. Iñarrea, J. Egido, and L. Hernando. Servicio de Nefrolo-
gia, Fundación Jiménez DIaz, Madrid Spain. The chemical structure
of APRL (alkyl-acetyl-sn-glycerylphosphocholine) has been recently
established and found to be analogous to that of platelet-activating
factor (PAF-acether), a potent mediator of inflammatory reactions.
Intravenous infusion of the compound at doses as low as 0.05 .sg
induced a fall in blood pressure from 108 6 to 60 10 mm Hg (means
SEM) pan passu with a drop in total peripheral resistance from 4.2
0.4 to 2.3 0.4 mm Hg.ml.m '•IOO g body wt, which explains the
reason why cardiac output showed no significant variation. Higher
doses induced prolonged hypotension, together with a marked deple-
tion of blood volume (as shown by an increase of the hematocrit of up to
25% and a rapid drop of the plasma level of previously injected
exogenous'251-serum albumin), which correlated with the time span of
the hypotension; again, no variations of cardiac output were observed,
although coronary, splenic, and renal flows (measured by using radiola-
belied microspheres) were reduced by 50, 79 and 87% of their previous
values. Among all the experiments no activation of circulating platelets
was observed. In conclusion, PAF-acether induces in rat vessels a
number of actions, in which activation of platelets does not seem to play
any role.
Abnormalities of the Na'4'-K'4'-transport system in essential hyperten-
sion (EH). P. Martin Vasallu, E. Battaner Arias, J. M. Tabernero
Rome. Hospital Clinico Universitario, Sala,nanca, Spain. Other inves-
tigators have reported an abnormal cation flux across the red cell
membrane in patients with essential hypertension (EH). We present
data on some activities associated with the so-called Na-K-pump in
15 EH patients (aged 37 to 64 years) compared to 12 normal controls
(aged 20 to 40 years). The ouabain-sensitive, Na-K-Mg2-dependent
ATPase activity in the red cell membrane was severely depressed in the
patients:
Controls Patients
Enzyme activitya 201.75 97.16 (Sn) 29.20 14.30 (so)
IS
"Activities are expressed as micromoles P/mg protein/hour
Also studied was the binding of 3H-ouabain to crude membrane
preparations. These experiments did not reveal any alteration in the
number of binding sites; however, EH membranes had an increased
affinity toward the drug (Kd lowered by an order of magnitude). These
data suggest a diminished activity of the pump in these patients,
probably related to the alteration of cation flux reported by others. Any
cause-effect relationship of these anomalies with the hypertensive state
could not be established.
Low-renin essential hypertension: Consequence of a deranged dopa-
minergic system? R. Garcia-Robles, L. Ruilope, F. Sanchez-Franco, A.
Hurtado, J. M. Alcazar, V. G. Millet, J. L. Rodicio, and J. Sancho.
Departmento de Endocrinology Centre 'RamOn y C'ctjat° , Depart-
mento de Nephrology CS., 11/0 de Octuhre,° Madrid, Spain. In a
group of five patients diagnosed with LREH (as defined by age below 45
years, normal renal function, serum potassium above 3.5 mEq/liter,
PRA below 3 ng/ml hr after 3 hr deambulation while on a lO-mEq
sodium diet and normal urinary excretion of A while on a 10- and 110-
mEq sodium diets), the function of the hypothalamic-pituitary axis has
been explored by studying: (1) the response of 'rSFl and PRL to TRH
administration (200 g iv.), (2) the response of cortisol (F) and OH to
insulin-induced hypoglycemia, (3) the response of FSH and LH to
LREH administration (100 tg iv.), (4) the circadian rhythm of F (9 A.M
and 2:30 P.M. determinations), and (5) the urinary excretion of free F
(FF). The values were compared with those obtained in a control group
(CG) of five normal volunteers and with those of six patients diagnosed
of normoreninemic essential hypertension (NEIL). The responses of
FSH, LH, OH, and F, the circadian rhythm of F and the urinary
excretion of FF were similar in the three groups. The response of 'FSH
and PRL to TRFI administration were increased (P < 0.01). The values
of PRL were (X SEM).
Basal IS mm 30 mm 60 mm
CG 10.2 0.9 49.1 8.3 34.2 6.4 22.6 7.1 ng/ml
NEH 15.3 1.2 50.! 10.3 36.5 8.9 21.0 6.8 ng/ml
LREH 10.6 2.0 99.6 21,3 85.6 18.9" 43.3 65h ng/ml
In LREH and CG the plasma levels of A were measured, in the
recumbent position, every 30 mm for 24 hr, while on a I lO-mEq sodium
diet. In CG, A showed the maximal peaks in the early morning hours,
whereas in LREH, A peaks were similar along the day, although A
values integrated over time were similar in both groups. 'l'he results
point to the existence in LREH of: (1) an altered dopaminergic system.
and (2) a situation of relative hyperaldosteronism. Both findings could
be related through the existence of a diminution of the tonic inhibitory
effect of dopamine on A secretion,
Adrenergic dysfunction in hypotensive hemodialysis patients. A. Botev,
J. Gaya, J. Montoliu, A. Torras, F. Rivera, J. López-Pedret, and L.
Revert. Hospital Cilnico, Barcelona, Spain. To ascertain the signifi-
cance of autonomic dysfunction in hypotensive (I-IT) maintenance
hemodialysis patients, plasma norepinephrine (NE) was measured by
radioenzymatic assay in 15 nondiabetic uremic subjects of similar age
and time on dialysis, five of them HT (predialysis systolic BP  100mm
Hg in 75% of occasions) and 10 normotensive (NT). HT patients had
significantly higher NE levels than NT patients, both in quiet basal
conditions (1124 277 (sEM) vs. 332 48 pg/mI, P < 0.01) and 5 mm
following assumption of the upright position (1551 343 vs. 613 107
pg/mi, P < 0.01). NE values in NT uremic patients did not differ
significantly from those obtained in normal control subjects. An intra-
venous NE infusion induced lesser increments in mean arterial BP in
the five HT than in six NT uremic patients, both at a dose of 85 ng kg'
min' (1.42 1.14 vs. 11.44 1.97mm Hg, P <0.01) and at a dose of
200 ng- kg' mm 1(946 2.35 vs. 26.16 4.57 mm Hg, P < 0.05).
Rather than implicating a mechanism based on autonomic neuropathy,
our results suggest that in hemodialysis patients with chronic hypoten-
sion there is a defect located at the adrenergic postsynaptic level.
Sympathetic response and blood pressure stability in isolated ultrafil-
tration (UF) and hemofiltration (HF) in comparison with hemodialysis
(HD). C. Gonzalez, J. Ludo, M. Resano, U. Barril, J. A. Ramos-
Atance, F. Valderrdbano. Servicio de NefrologIa, Hospital Provincial,
Departamento de Bioquimica, Facultad de Medieina, Universidad
Cornplutense, Madrid, Spain. To investigate the better tolerance to
volume depletion in UF, compared with I-ID, changes in mean arterial
pressure (MAP); heart rate, K, osmolahty, and norepinephrinc (NE) by
a radioenzynsatic method have been studied in eight patients in regular
HD without evidence of automatic neuropathy (normal response to
Valsalva maneuver) and with a uniform loss of weight (3 to 4% of body
weight) were submitted to the following procedures: acetate HD(AHD).
bicarbonate HD(BHD), acetate HF, and UF. In open and closed circuit
ap = NS; bp < 0.01
N 12
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AHD a significant depression of MAP (97 to 76, P < 0.005 and 98 to 84,
P < 0.005, respectively) was shown. In BHI) a decrease of MAP was
also observed but was not statistically significant and in HF and UF the
MAP was unchanged. Bradycardia occurred in UF, tachycardia in
AHD, and there were no changes in heart rate in HF. Osmolality was
lowered significantly in all procedures, except UF. Plasma K was
unchanged in HD and HF. Plasma NE decreased in HD (closed circuit
294 62 to 254 47 and open circuit 272 78 to 234 48 pg/mI. P <
0.02), was unchanged in BHD, and raised in UF and HF (226 64 to
326 230 and 246 69 to 337 179 pg/mI, P < 0.05). Mannitol
perfusion (20%, 0.25g/kg/hr) during AHD prevented changes in osmo-
lality in all patients, but MAP decreased from 97 II to 88 9 mm Hg.
Symptoms (cramps and vomiting) were common in ADH, less frequent
in BHD, and very rare in HF and UF. Stability of MAP in HF, despite a
similar decrease in osmolality does not play a critical role in mainte-
nance of arterial pressure in UD. The better tolerance to BHD may be
related with vasodilatatiori provoked by acetate whereas the hemody-
namic stability found in HF and UF may be explained by a better
sympathetic response whose mechanism is unknown.
Cardiovascular response to hemofiltration and hemodialysis. Influence
of the alkalinizing agent used. P. AIjama, A. Martin-Mob, R. Sanz, J.
Pasalodos, M. Sancho, F. Moreno, J. Fernandez, J. Gornez, R. Perez,
M. Serrano, and L. G. Burdiel. C. S. Reina Sofia", University (tf
Cordoba, Cordoba, Spain. Hemofiltration (HF) induces better cardio-
vascular stability than hemodialysis (HD). The main factor of this
difference remains conflictive: direct hemodynamic effect of solute
transport or influence of the alkalinizing used. in the present investiga-
tions the effectiveness of cardiovascular compensatory mechanisms
during HF and HD were evaluated. Four groups of ten patients were
studied: HF with lactate (LA), HF with acetate (AC). HD with AC and
HD with bicarbonate (BI). Stroke volume, cardiac index (CI) and
peripheral vascular resistance (VR) were evaluated by m-mode echo-
cardiography (coefficient of variation, 8%). In addition myocardial
performance was estimated by calculation of the ejection fraction (EF)
and velocity of circumferential fiber shortening (VC). Results were
compared with that obtained during isolated ultrafi]tration and diffu-
sion. During HF there were no significant changes in blood pressure
(BP) or pulse rate (PR). Cl fell, HF-LA (5.6 to 4.5), HF-AC (5.3 to 4.8)
P <0.02; VR increased, HF-LA (22 to 26), HF-AC (20 to 25) P <0.025;
and myocardial function improved (+ 14%) but not significantly. During
HD-AC BP decreased (P < 0.001) and PR increased (P < 0.005), with a
fall in VR (22 to 17) P < 0.005. CI remained constant. EF and VC did
not change (—3% and —1%; NS). During FID-BI, BP and PR were
maintained; CI slightly (5 to 4.6; P < 0.05) decreased; VR remained
stable (22 tn 21) NS. Myocardial performance significantly improved
EF (+26%, P < 0.05) and VC (+30%, P < 0.005). Results obtained
during ultrafiltration were identical to HF (variance analysis). It is
concluded that convective transport induces an increase of VR compen-
satory to the Cl fall consecutive to the volume depletion; the cardiovas-
cular stability observed during HD-BI can be due to the maintenance of
VR and improvement of myocardial performance, which is objectified
even during isolated diffusion.
Sequential hypertonic dialysis. New technique of asymptomatic ultrafil-
tration. P. Aijama, A. Martin-Main, R. Sanz, M. Serrano, F. Moreno,
J. Fernandez, J. Gornez, R. Perez, and L. G. Burdiel. C. S. Reina
Sofia," University of Cordoba, Cordoha, Spain. Occasional patients
show severe hypotension with fluid overload during hemodialysis. In
this setting ultrafiltration is troublesome due to early hypovolemic
symptoms. High sodium concentration in the dialysis fluid (DF) helps,
but hypernatremia limits its use in a long-term run. We have studied the
practicality and advantages of alternate very high sodium concentration
in the DL performing sequential hypertonic dialysis (SHD) in two
patients (authonomic neuropathy and myocardiopathy). DF containing
185 to 190 mEq/liter of sodium during the first and third hour and 132
mEq/liter during the second and fourth hours were used with an original
electronic modification of a Drake-Willock-Bi proportionating monitor.
The study was controlled and crossover was made (2 cycles): 3 weeks
of conventional hemodialysis (CH) 132 mEq/liter of sodium and 4 weeks
of SHD; ultrafiltration rate was recorded. During SHD more fluid had
been removed than CH (3.8 kg vs. 1.7, P < 0.001). Mean arterial
pressure did not change with SHD (—5.7%, NS) and decreased with CH
(—21%, P < 0.001). Plasma osmolality remained constant during SHD
(—1.8%, NS) and fell during CH (—9.9%, P < 0.001). Major dialysis
complications were documented in 14% of SHD and 52% of CH (P <
0.001). Plasma volume (1311 dilution) decreased 5.1% (NS) during SHD
and 19.6% during CH (P < 0.001). Residual uremic symptoms (self-
administered questionnaire) improved during SHD. There were no
hypernatremia and at the end of each SHD cycle the hemoglobin,
potassium, and phosphate levels improved (P < 0.025). When plasma
volume, loss of weight, and sodium balance were evaluated, an
important intracellular overhydratation was suggested in these patients.
it is concluded that the overall experience during 6 months, in addition
to the results of this controlled study, demonstrates that SHD is an easy
and reliable procedure with our methodology. Also, dry weight can be
achieved rapidly without hypovolemic symptoms, and there is a better
biochemical control during SHD, which constitutes a satisfactory
alternative to periodic sequential isolated ultrafiltration in patients with
frequent dialysis-related hypotension.
Mechanism of hemodialysis-related leucopenia. P. Aljama, J. SI.
Garin, R. Sanz, A. Martin-Mabo, F. Moreno, and A. Torres. C. S.
Reina Sofia", University of Cordoba, Cordoha, Spain. The present
studies were carried out to evaluate the role of granulocyte margination,
medular response, and complement activation in the mechanism of
hemodialysis leucopenia. Differential white cell count, granulocyte
adherence (ADH) by nylon fiber column assay (coefficient of variation
8.7%), total complement activity (CH5O), and C3 breakdown products
(C3d) were estimated in ten patients using cuprophane membrane (CU)
and in ten polyacrylonitrile (PAN). in vitro studies were also performed
with isolated cells separated by centrifugation gradients. CU induced
maximal neutropenia at 15mm of hemodialysis (P <0.001) which was
associated with a striking increase in ADH (+247% of initial value, P <
0.001). At 60 mm neutropenia recovered as well as ADH (+35%, NS);
there was only partial medular response of band neutrophils (56 to 126.
P <0.02 at 60 mm). CH5O fell (—19%) and C3d increased (+40%). P <
0.02, indicating activation of complement. There was no significant
neutropenia with PAN; ADH remained constant (only +7%. NS at IS
mm). However, complement activation was documented (CHSO:
—17%; C3d: +35%, P < 0.025) as during CU hemodialysis. The
incubation of granulocytes obtained before hemodialysis resuspended
in plasma obtained at 15 mm increased ADH + 216% with CU and only
14% with PAN. When this plasma was decomplemented (56° C. 30 mm)
ADH also augmented (+240% with CU). The same ADH changes were
documented with granulocytes from normal individuals were incubated
with ABO compatible plasma of patients in hemodialysis (+ 265% with
CU and 1.8% with PAN). These results suggest that the mechanism of
hemodialysis-related leucopenia is a transient increase in granulocyte
ADH, which depends on the type of membrane used. The augmenting
ADH factor seems dissociated of complement system since PAN
induces complement activation but no leucopenia; in addition, it is
termostable. This factor is able to show its high activity even with
granulocytes of normal subjects.
Dialysis-induced leucopenia and complement activation: Differences
between hemodialysis (HD), hemofiltration (HF), and isolated ultrafiltra-
tion (UF). S. G. de Vinuesa, M. Resano, J. Luno, C. Gonzalez, G.
Barn!, and E. Junco v F. Valderrdbano , Servicio de nefrobogia.
Hospital Provincial, Madrid, Spain. The decrease in the peripheral
count of leucocytes in the oxygen partial pressure (PaO2) and comple-
ment activation are phenomena which occur during the first hour of HD
and whose etiology are now a controversial issue. To investigate the
pathogenic mechanisms of these three phenomena, we studied eight
hemodialysis patients sequentially subjected to different dialysis proce-
dures: HD with acetate as a buffer (AHD), cuprophan membrane (CP).
and poliacrilonitrile membrane (PAN); HD with bicarbonate (BHD);
HF with acetate fluid and acetate cellulose membrane, and UF with a
PAN membrane. In all patients blood was drawn from the arterial line at
the start of IS and 30 mm after the start and hourly during each
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procedure to determine PaO (Technicon blood gases analyser), leuco-
cyte count (Counter Coulter), total hemolytic complement (CH-100),
activity of the alternative pathway (AP-l00. after inactivating the
classic pathway with EGTA-Mg), and C, C4, and B factor (radial
immunodiffusion). With the use of the CP membrane, a marked
leucopenia was observed 15 mm after the start in both AHI) (5,480
900 to 2,100 700) and BHD (5,310 800 to 1,910 580, P < 0001).
At the same time, the total complement level descended 32% (P < t).01)
in the AHD patients and 22% (P < 0.05) in the BHD. In FID with PAN
membrane and in HF with acetate cellulose membrane, the decrease in
the leucocyte count was not marked (5,900 690 to 4,700 500, 5,460
500 to 4,340 400, respectively); however, an important decrease of
the CH-100 is associated (38% and 30%, respectively; P < 0.01). The
AP-100, C, and B levels suffered a parallel decrease although not
significant, without any variation of C4 levels, all of which prove that
the complement is activated through the alternative pathway. In hF
with PAN the leucopenia is not important and the complement is not
activated. Significant hypoxia only appears in AHD even with PAN and
is most marked 60 mm after the start. In conclusion, from these data,
we can infer that the leucopenia during dialysis depends on the
membrane used and is not the cause of the hypoxemia, which may be
related to the use of acetate during dialysis. The complement activation
through the alternative pathway is not related with the level of
leucopenia, does not appear in UF with PAN, and can be considered an
independent phenomenon.
Dialysis osteomalacia: Histomorphornetry and response to 1/25 (011)2
cholecalciferoL A. L. Martin de Froncisco, S. Palacio,r, .1. Avedillo, F.
Sousa, M. Arias. J. Gonzalez—Coiorruelo, P . [tiara/es, S. Sanz de
C'aslro, J. A. Zuhimendi, and C. Llamazares. Centra Medico Nacional
''Marques de Valdecilla,'' Sers'icio de IVeJro/ogio, Santander, Spain. A
type of dialysis osteomalacia, presenting in our medical unit, with
fractures and dementia is reported. Fourteen patients showed multiple
fractures, mainly in the ribs and pelvis. There was no radiological
evidence of suhperiosteal resorption. Static morphometry of iliac crest
biopsy specimens disclosed an overall increase of osteoid and no
evidence of osteitis fibrosa. The increased levels of iPTH-COOH
terminal were unrelated to osteoclasia, which was quantitatively nor-
mal. All patients received a 6-month treatment with 1/25 (OH)-, chole-
calciferol with no clinical or radiological improvement. In six patients a
second bone biopsy showed no significant changes. This treatment in
some patients triggered hypercalcemia and meta.stasic calcifications.
The group of patients developing fractures and dementia stayed under
dialysis treatment longer (3 to 5 years) with aluminium rich nondeion-
ized water, than those not presenting this syndrome (I to 4 years).
Peritonealclearanceofparathormone (CPTII). J. L. Migue/Alonso, M.
F. Martinez, R. Se/gas, M. Ccisares, P. (jO,nez, and L. Sanchez Sicilia,
Department ofNephro/agv andLaboratory, C. S. ''La Paz.'' Authono—
mans Llniversilv of Madrid, Madrid, Spain. Since PTH circulating
l'ragments have a molecular size in the range of the "middle molecules"
and continuous ambulatory peritoneal dialysis (CAPD) is more effective
than intermittent peritoneal dialysis (IPD) on their removal, estimations
of peritoneal clearance of PTI-I on both procedures were attempted.
Peritoneal clearances of urea, creatinine, phosphate, albumin, and PTH
were done in 12 patients on CAPD (4 exchanges/day) and nine patients
on IPD (40 exchanges/week). Blood samples were drawn halfway in the
first morning exchange on CAPD, and in the second and 20th exchanges
on IPD. IPD clearance values were the media between the second and
20th clearance values in each patient. PTH was measured by the C-
terminal specificity by means of a commercial kit. C55.,, Ce,, C1, and
CA!h results were similar to (hose previously reported. CmrH was 12.4
3.7 on CAPD and 8.3 2.2 liter/week/l.73 as2 on IPD. It was a very
good relationship between plasmatic and dialyzed PTII levels (V =
7.62x + 2.3;r 0.83 andP <0.001); between and Cr(y = l.4x +
3.59; r = 0.81 and P < 0.001) on CAPD. PTH plasma levels were
unchanged before and after the 20th exchange IPD treatment. The
plasmatic and residual peritoneal fluid level of PTH on IPD kept a
similar concentration. In conclusion, (I) an important loss of PTH
through the peritoneum exists; (2) there is a good correlation between
serum and peritoneal fluid levels on CAPD. and between PTH and
ereatinine peritoneal clearances; (3) plasma and residual peritoneal fluid
PTH on IPD showed a similar concentration; (4) protracted loss of PTH
through peritoneal membranes in patients on long-term CAPD treat-
ment may modify PTH serum levels, but late evolution of renal
osteodystrophy cannot be anticipated.
Study of calcitonin levels (CT) in patients on periodic hemodialysis
(HD) and its posterior changes after renal transplantation (TR). F.
Junco, R. Perez Garcia, S. Alonso, A. Caballero, F. Vasconez, A. del
Castillo, and F. Valderrdhano. Sen/cia de Nefrologia y Seccidn de
Radioinmunoanalisis, Hospital Provincial, Madrid, Spain. The role of
CT in the modifications of the Ca-P metabolism in patients on HD is not
well known. One hundred ninety-six simultaneous serum determina-
tions of CT (RIA); PTH (RIA); Cail (selective electrode); total Ca and
Mg (atomic absorption); P and alkaline phosphatase (AP) were done on
116 patients submitted to HD evaluating at the same time the
symptomatology and bone roentgenograms. In 28 patients with func-
tioning TR, 57 determinations of the same protocol were practiced.
Fourteen of the patients on HD received I aOH-D5 treatment. Six
parathyroideetomized patients on I-ID were also evaluated. The serum
CT levels of patients on HD are elevated with respect to 37 patients in
the normal control group (18.8 8.4 vs. 8 4 nU/ml, P <0.001). The
patients with Ca level > 2.25 mEq/liter present higher CT than those
with Ca < 1.9 mEq/liter (20.1 6.4 vs. 16.1 7.4 nU/ml, P < 0.025).
which could imply a Ca/CT relation in these patients. Patients with
elevated AP present higher serum PTH and lower serum CT than those
with normal AP levels (P < 0.005) and are also associated with mare
severe hyperparathyroidism under radiological criteria. Patients sub-
mitted to I aOH-D5 treatment who present an increase of Ca and a
decrease of PTH and AP during the treatment, increase their level of
CT. We have not observed modifications in the CT levels postparathy-
roidectomy. After a functional TR (creatinine 2 mg/dl) the CT levels
decrease progressively in relation to the glomerular filtration rate and to
the time of evolution (r =
—0.97), reaching normal levels 6 months post-
TR. Patients transplanted with creatinine > 3 nig/dI show a decrease of
CT levels without ever reaching normal levels. In conclusion, the CT
level is increased in patients on HD. creating a Ca/CT relationship in
patients with an elevated Cail which implies a possible Ca control
over the CT secretion. The PTH/CT ratio is higher in patients with very
severe hyperparathyroidism. The changes observed in the Cf levels
after a functional TR are similar to the ones observed in the I'TH levels.
which has been attributed to a progressive recuperation of the parathy-
roid hyperplasia. A similar mechanism could he implied within the
thyroid gland to explain the recuperation of CT levels post-TR.
Serum vitamin B12 (B12) and folk acid (FA) levels in patients on chronic
hemodialysis (HD) and hemoliltration (HF). E. Junco, S. Alonsa, S. Ga
Vinuesa, J. Luno, F. Vasconez, A. Caballero, F. Anava, and F.
ValderrObano. Servicio de Nef rologIa v Sección de Radioin,nanoa,uili—
si,v, Hospital Provincial, Madrid, Spain. The loss of B12 and FA through
the dialysis membrane can cause a chronic depletion and contribute to
the anemia found in HD patients. The predialysis serum levels of B12
and PA (RIA) in 70 patients on I-ID and eight patients on periodic HF
were studied. All patients received a protein unlimited diet. The (ID
patients were divided into two groups: group A with 34 patients who
were given intravenous B, (500 zg) and FA (250 jng) at the end of each
HD session, and group B with 36 patients who did not receive B,2 or
FA. The HF patients received the same supplements as group A. The
levels obtained from 36 normal subjects served as the control group.
Levels of B,, and FA were measured in dialysate and ultrafiltrate to
determine the losses during each technique. (iroup A patients had
higher B,2 (2093 608 pg/mI) and FA (5.1 1.2 ng/ml) levels than
group B (B,2, 627 262 pt/mI; FA 3.5 1.3 ng/ml) and than the control
group (B,, 363 lOt pg/nil; FA 3.8 1.2 ng/mI, 1' < 0.01). In group B
the median level of FA was normal although ten patients had low levels,
and the median B12 levels were high despite not receiving any of the
supplements (P < 0.01). The B,2 levels of patients submitted to HF
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were high (1042 135 pg/mI), although they were lower still than group
A's levels: on the other hand, they presented low levels of FA (2.4 0.9
ng/ml), despite the routine administration of supplements (P < 0.01).
The loss of B12 through the membrane is important in both HD and HF
and it holds relationship with the serum levels, The loss of FA during
HF is higher than the one observed during HD and could justify the low
serum levels found in these patients. To conclude, the B12 levels are
elevated in all HD patients, even in those not receiving supplementary
vitamins, and therefore, its continuous administration is unnecessary.
The use of supplements of FA in these patients should depend on the
serum level found and should not be administered routinely. The
patients submitted to HF, on the other hand, need to receive large doses
of FA to compensate the important losses occurring during HF.
HLA A3, B7, and B14 (hemochromatosis alleles) and the serum ferritin
in patients on maintenance hemodialysis. F. Ortega, F. Gdmez, F. Ga go,
J. M. Morales, M. Ba/los, F. Fernández Vega, and J. Alvarez Grande.
Servicio de Nefrologla, C. S. Ntra Sra de Covadonga, Oviedo. Spain.
The present study was undertaken to assess whether or not patients
with one or more HLA antigens (A3, B7, or Bl4) associated with
idiopathic hemochromatosis and, therefore with iron metabolism,
showed a greater serum ferritin level than patients without these
antigens. HLA type, hemoglobin, serum-iron, transferrin, ferritin,
erythropoietin, vitamin 2, serum-pholate, haptoglobin, and LDH
concentrations, reticulocyte count, and number of transfusions were
determined in 40 patients (28 males, 12 females: age range, 17 to 61
years) on maintenance hemodialysis for tO to 132 months. Another 19
patients were included without HLA type. No patient had evidence of
clinical myopathy or active liver disease. Oral intake of iron was similar
in all patients. Mean (± sEMI serum ferritin level of 12 patients with
"hemochromatosis alleles" (1048 183 ng/ml) was significantly greater
(P 0.001) than 28 patients without these alleles (414 8! ng/ml). Mean
ages (34.8 and 42 years, respectively) were found significantly different
in both groups (P 0.05). but in none of the rest of the determinations.
Hemoglobin level (8.17 0.40 g/dl). number of transfusions (8.9 1.4
U), serum-iron (112 8.4 gammas/dI) and transferrin concentrations
(219 10 mg/dl) in 14 patients with serum ferritin above 1000 ng/ml
were significantly different than that in 45 patients with serum ferritin
levels below 1000 ng/ml (10 0.34 g/dl; 5.9 0.67 U; 89.7 5.4
gammas/dI and 178 4.2 mg/dl). A significant correlation was found
between the presence of "hemochromatosis alleles" and serum ferritin
levels:
Serum ferritin
ng/ml Hemochromatosis allele
>1000 8/10
<1000 4/30
P < 0.01
Patients on maintenance hemodialysis with HLA A3, B7, or B14 are at
an increased risk of iron overload. Raised serum-fernitin levels are
related inversely with low hemoglobin concentrations and related
directly with the number of transfusions. These findings are indepen-
dent of HLA type.
Practical attitude in dialysis units with the new markers of hepatitis B.
R. Matesunz, J. L. Teruel, R. Buena, J. Gonzalez, R. Marcén, L.
Orofino, C. Quereda, and J. Ortri/lo. Nep/iro/ogv Service arid Virology
Lab, Centro Ramon v Cajal, Madrid, Spain. The discovery and
introduction in clinical routine of the new markers of hepatitis B raised
questions about its real significance and especially about eventual
preventive isolation measures with Ac anti-HBc+ patients. Since 1979
to 1981, the incidence of virus B markers (AgHBs, Ac anti-HBc, and Ac
anti-HBs) was studied prospectively in a one-room dialysis unit with 16
beds. AgHB5 (R.I.A.) and serum alanin transferases (SMAC-20) were
determined every month: Ac anti-HBc and Ac anti-HBs were investi-
gated yearly. Also, whenever an enzymatic elevation was detected,
after ruling out drug toxicity, a wide virological screening was done
(Epstein-Barr virus, CMV, 1gM anti-virus A. Ac anti-HBc, and Ac anti-
HBs). Three patients were AgHB5 + before starting dialysis treatment
and were always treated in an isolated room. In 1979, 13 of 55 patients
(23.6%) were Ac anti-HBc +. ten of them also Ac anti-HBs +. During
the following year, these patients were dialyzed in the same room but in
separate machines. In 1980, three of these patients became Ac anti-HBc
—, and two were transported to other units: however, two new patients
became Ac anti-HBc +. As a whole, II of 64 were Ac anti-HBc +
(17.1%) and nine of them Ac anti-HBs +. After this moment, all
patients were dialyzed indistinctly in all machines with no isolation
measures. One year later. one more patient became Ac anti-HBc —, and
none became +, thus resulting nine of 54(16.6%) Ac anti-HBc + and all
of them Ac anti-HBs +. During the period of the study, no patient
became AgHB5 23 enzymatic elevations, mild to moderate, without
jaundice, were detected (one of eight, one patient per year), and none of
them could be attributed to the virus B. In conclusion, low infectivity of
Ac anti-HBc + patients was found. Isolation measures with them seem
to be unnecessary. From a practical point of view, AgHB5 detection by
RIA is enough for hepatitis B prevention. Only AgHB5 + patients
should be isolated.
The localization of transplantation antigens HLA-ABC and DR in
human kidney. Pedro Errasti. Susan Fuggle, Abdul Daar, Alan Ting,
John Fabre, and PeterJ. Morris. NuffieldDepartrnent of Surgery, Jo/in
Radcliffe Hospital, Oxford, England. It is well established that trans-
plantation antigens (HLA) are the targets of antibodies responsible for
kidney graft rejection. An estimate of the amount of HLA antigens
within the human kidney has been shown previously. The DR antigens
are expressed six more times than HLA-ABC antigens. The precise
localization of these antigens within the kidney may explain why DR
matching improves graft survival. Monoclonal antibodies to monomor-
phic HLA-ABC (GD-5), DR antigens, and polymorphic or individual
HLA antigen determinants (A2, B7) were used in peroxidase-antiperox-
idase technique (PAP) to localize these antigens in 50 pretransplant
kidney biopsy specimens. Monoclonal antibodies to leukocyte common
antigen (LC) and against human and dog thy-I were used as specificity
controls. Monoclonal antibodies to DR antigens stain strongly glomeru-
Ii, penitubular capillaries (PTC), and interstitial cells, but large vessels
are usually negative. Monoclonal antibodies to monomorphic HLA-
ABC stain glomeruli, large vessels, and PTC. All the kidney donors
typed as A2/B17 or B7/B22/B27 are positive with the polymorphic
antibodies and have similar distribution to monomorphic HLA. The
antileukocyte common antibody strongly strains intertubular interstitial
cells but does not stain endothelial cells. Human thy-I is localized in
some tubules and the Bowman capsule; dog thy-I is not expressed in
human kidney (negative control). The follow-up with post-transplant
kidney biopsy specimens in the localization of these antigens and their
variations, especially in the expression of the polymorphic antigen
determinants, could give some insight into the understanding of long
surviving renal grafts.
Characterization of cytotoxic antibodies after renal transplantation.
Pedro Errasti, Lois M. Pallardo, Alan l'ing, and Peter J. Morris.
Nuffield Department of Surgery, John Radcliffi' Hospital, Oyford,
England. Serum samples collected weekly during 2 months after
transplantation from 57 recipients of cadaver donor renal transplants
were screened for cytotoxic antibodies. The follow-up was between 3 to
21 months. The target panels used were T and B lymphocytes and
monocytes (M) from 20 normal volunteers and B lymphocytes from 20
patients with chronic lymphocytic leukemia (CLL), all typed for HLA-
ABC and DR. In addition, the sera of 43 recipients were tested against
the B lymphocytes of the specific donor, According to the degree of
reactivity, 15 patients were reactive against 10% of the panel, II
patients against 11% to 50%, 19 patients against 51 out of 80%; II
recipients had broadly reactive antibodies against more than 81% of
panel. No correlation was found between the presence or development
of cytotoxic antibodies and the onset of acute rejection or graft survival;
the incidence of graft rejection was 33, 25, 32, and 36%, respectively.
The patients with positive antibodies (reactive with at least 10% of the
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panel) were categorized according to their specificity related to reactiv-
ity against TBM, TB, BM, B, M. and CLL as follows: group I, reactive
against TBM or TB plus CLL (HLA-ABC); group 2, reactive against
BM or B plus CLL (HLA-DR); and group 3, antibodies not reactive
with CLL (autoantibodies).
In conclusion, no correlation was found between the level of antibodies
and graft survival, even when the level of cytotoxicity was > 81%.
There was no relationship between the appearance of donor-specific B
lymphocytes antibodies after transplantation and graft failure. The lack
of reactivity of the antibodies with CLL could he of prognostic value.
The effect of a transfusion program on the incidence of B hepatitis and
on the cytotoxic antibodies level. G. Barril, C. Gonzalez, J. Lubo, M.
Resano, A. G. Pineda, and F. Valderrdbano .Servicio de NefrologIa y
Sección de He,natologia, Hospital Provincial, Madrid, Spain. The
better tolerance has been observed toward the transplanted tissue in
patients who received multiple transfusion in regular hemodialysis
treatment (HD) while waiting for a suitable transplant donor. To
evaluate the possible adverse effects of a transfusion program, 62
patients who received a medium of 6'9/patient/year programmed trans-
fusions (units of concentrated red blood cells) were studied during a
period of 12 months (group A). in comparison with the data obtained
from 33 patients submitted to HD in our satellite unit who received 36/
patient/year transfusion during the same time due to worsening of the
anemia because of an increase in the level of chloramines in the water
(group B). One hundred eight patients in HD who were studied the year
prior to their entrance in the transfusion program comprised our control
group (group C). In all these patients Ag HBs, Ac HB core, and Ac HBs
were determined trimestrally by RIA, and the level of cytotoxic
antibodies were determined every 2 months by the lymphocytotoxicity
method mediated by complement. The screening for Ag HBs in our
blood bank is done by an enzyme method. In group A, a positive shift of
B virus markers was observed in 30% of the patients. During the same
period of time, a shift was observed in 27% of the patients within group
B, and the incidence in our I-ID patients the year before was 17%. In
45% of the patients in the transfusion program an increase of the liver
enzymes (GOT, GPT) was observed in comparison with the increase
observed in only 24% of the patients in group B. The level of cytotoxic
antibodies increased in 33% of the patients in group A, in 29% of those
in group B and 50% of the patients in group C. In conclusion, the
increase in the number of transfusions given to patients on HD
constituted a definite risk of hepatitis especially due to B virus and, on
the other hand, it does not seem to influence the increase in the level of
cytotoxie antibodies in any way. The practice of a pretransplant
transfusion program requires a strict screening method for B virus in
donor blood, perhaps by a RIA method to determine Ag HBs or Ac HB
core to avoid the risk of transmitting hepatitis.
Low doses of corticoids in renal transplant. .1. A ndreu, A. Caraips, A.
Brulles, M. J. Ricart, F. Oppenheimer, J. Vilardell, J. Andreu Nat'arro,
and E. Esteller. Hospital Clinico y Provincial, Unidad de Trasplante
Renal, Barcelona, Spain. Thirteen patients transplanted from a cadaver
donor (CT) and 15 from a related haploidentical donor (RT) were
treated with low doses of prednisone (5 to 10 mg/dl). These doses were
reached between 6 and 43 months after surgery in the CT (average 17
months), and between 8 and 76 in the RT (average 37 months). If there
was no rejection crisis (R) these doses were maintained for over 6
months: between 2 and 102 months in the CT (average 23 months), and
between 4 and 100 months in the RT (average 36 months). Only two out
of the 13 CT, and one out of the IS RT presented rejection crisis at 2.4,
and 13 months, respectively, after low doses were reached. Comparing
this group of patients with a similar group treated with higher doses, it is
concluded that it is possible to reduce prednisone doses to minimum
levels after 6 months after surgery. In seven CT and three RT low doses
were reached within 6 months after surgery (average 2.8 in CT and 2.6
in RT). Three out of the seven CT and one out of the three RT showed
no rejection crisis after a period of 7 to 20 months with these doses.
However, four CT and two RT had rejection, solved totally or partially
with the usual treatment. Due to the small number of patients in this
group, whether these minimum doses may or may not he reached
without risk of further rejection within the first 6 months after surgery
cannot be assured.
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The Medical Research Council Glomerulonephritis Registry. Working
Par/v on the Treatment of Glomerulonepliritis. Department of Renal
Medicine, St. James's University Ho.rpital, Leeds, England. In March
1978 the Medical Research Councils Working Party on the treatment of
glomerulonephritis established a registry to record information on renal
biopsies performed in 19 centers throughout the United Kingdom. Since
then details have been recorded on some 2643 biopsies. A clinician from
each center reports clinical information (age, sex, presentation, pres-
Graft outcome
Successful
Failed
No. Group 1 Group 2 Group 3
28 II 9 8
13 12 1 0
______ _________ ____________________
Indium.1lI-labelled platelets in the diagnosis of kidney allograft rejec-
—-
tion. J. M. Grino, J. Martin-Comin, M. Roca, R. Nogues, A. M.
_____________________________
Castelao, 3. Alsina, and A. Caralps. The Department of Nephrology
and Nuclear Medicine, "PrIncipes de Espana'' Hospital, Barcelona,
Spain. The usefulness of a diagnostic method for kidney rejection has
_______________________________________
been studied based on the image of the graft area secondary to the
trapping of autologous platelets labelled with '°In-oxine in 20 renal
cadaver transplant recipients. Platelets were labelled according to
Hawker's method and then reinjected intravenously. Scintigraphic
image was obtained at 4, 24, 48, and 72 hr after injection. The trapping
index was calculated according to the graft activity versus contralateral
fossa iliaca ratio. Diagnosis of rejection was based on clinical, biochem-
ical echographic, 311-hippuran scintigraphic and/or histological criteria.
Four patients with a functioning allograft transplanted 2 to 6 months
previously and used as a control group showed no platelet trapping.
There was an uptake in 12 patients with acute rejection (mean trapping
index, 2.35 6) and in one patient with chronic vascular rejection. No
platelet uptake was observed in three patients with sudden impairment
of renal function due to acute tubular necrosis, urinary tract obstruc-
tion, and main renal artery thrombosis. The injection of '°In-oxine-
labelled autologous platelets is a useful method to detect kidney graft
rejection.
